Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

HLA phenotypes as promoters of cardiovascular remodelling in subjects with arterial hypertension

Journal of Human Hypertension volume 17, pages 63–68 (2003)Cite this article

Abstract

The objective of this study was to investigate the association between human leukocyte antigens (HLA) phenotypes and cardiovascular remodelling, as expressed by left ventricular mass (LVM) and carotid intima–media thickness (IMT), in hypertensives. We examined 153 subjects with arterial hypertension and 61 normotensive controls living in the greater Athens area. The population was classified into three groups and specifically group I (normotensives), group II with Grade 1 hypertension and group III with Grade 2 or 3 hypertension. HLA class I and class II antigens were studied by microlymphocytotoxic technique. Carotid IMT and LVM were determined by ultrasonography. The prevalence of HLA DQ7 in the hypertensive cohort was 27.4% that was significantly smaller than the 52.5% among the controls (P=0.002). The HLA DR11 was found in 24.0% of the hypertensives and in 52.5% of the controls (P<0.001). Group III hypertensives with HLA DR11 exhibited significantly higher LVM/h in comparison to the hypertensives without this HLA (199.0±28.8 vs 171.2+44.1g/m, P=0.009). This association was not present in groups I and II. Similarly, group III hypertensives with HLA DQ7 were characterized by higher IMT in comparison to those without this HLA (0.94±0.19 vs 0.83±0.23 mm, P=0.048). HLA DR17 was associated with higher IMT in both groups II and III (1.00±0.19 vs 0.82±0.19 mm, P=0.046 and 1.01±0.23 vs 0.84±0.22 mm, P=0.049, respectively) but not in group I. In conclusion, certain HLA phenotypes may be related to the levels of arterial blood pressure. Moreover, it seems that these HLA phenotypes may identify subjects with arterial hypertension that are more prone to develop cardiovascular hypertrophy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Ganau A et al. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990; 81: 25–36.

    Article  CAS  Google Scholar 

  2. Lauer MS, Anderson KM, Levi D . Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: The Framingham Heart Study. J Am Coil Cardiol 1991; 18: 1287–1294.

    Article  CAS  Google Scholar 

  3. Verdecchia P et al. Circardian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528–536.

    Article  CAS  Google Scholar 

  4. Saba PS et al. Relation of carotid pressure waveform to left ventricular anatomy in normotensive subjects. J Am Coll Cardiol 1993; 22: 1873–1880.

    Article  CAS  Google Scholar 

  5. Mannami T et al. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke 1997; 28: 518–525.

    Article  CAS  Google Scholar 

  6. O'Leary DH et al. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14–22.

    Article  CAS  Google Scholar 

  7. Drayer JI, Weber MA, DeYoung JL . BP as a determinant of left ventricular mass. Arch Intern Med 1983; 143: 90–92.

    Article  CAS  Google Scholar 

  8. Iwai N, Ohmishi N, Nakamura W, Kinoshita M . DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622–2628.

    Article  CAS  Google Scholar 

  9. Castellano M et al. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation 1995; 91: 2721–2724.

    Article  CAS  Google Scholar 

  10. Lindpaintner K et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996; 334: 1023–1028.

    Article  CAS  Google Scholar 

  11. Tao Z et al. An association study between essential hypertension and HLA-DR1 alleles. Chin Med Sci J 1995; 10: 70–72.

    CAS  PubMed  Google Scholar 

  12. Luque Otero M . Severe hypertension in the Spanish population. Association with specific HLA antigens. Hypertension 1983; 5: V149–V152.

    Article  CAS  Google Scholar 

  13. Diamantopoulos EJ et al. Association of specific HLA phenotypes with left ventricular mass and carotid intima–media thickness in hypertension. Am J Hypertens 2001; 14: 632–636.

    Article  CAS  Google Scholar 

  14. 1999 World Health Organization–International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17: 151–183.

  15. Terasaki PI et al. Microdroplet testing for HLA - A, -B, -C, and -D antigens. Am J Clin Pathol 1978; 69: 103–120.

    Article  CAS  Google Scholar 

  16. Vartdal F et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation—a fast and reliable technique. Tissue Antigens 1986; 28: 301–312.

    Article  CAS  Google Scholar 

  17. Sahn DJ, DeMaria A, Kisslo J, Weyman A . Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.

    Article  CAS  Google Scholar 

  18. Devereux RB, Reicheck N . Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613–618.

    Article  CAS  Google Scholar 

  19. Campbell MJ, Machin D Medical Statistics: A commonsense approach, 3rd edn John Wiley: Chichester, UK 1999, 148 pp.

    Google Scholar 

  20. Brostoff J, Scadding G, Male D, Roit I (eds). Clinical Immunology, Gower Medical Publishing, London 1992.

    Google Scholar 

  21. Frohlich ED et al. The heart in hypertension. N Engl J Med 1992; 327: 998–1008, [Erratum, N Engl J Med 1992; 327: 1768.]

    Article  CAS  Google Scholar 

  22. Chambers J . Left ventricular hypertrophy. BMJ 1995; 311: 273–274.

    Article  CAS  Google Scholar 

  23. Harris EL et al. Heart mass and blood pressure have separate genetic determinants in the New Zealand genetically hypertensive (GH) rat. J Hypertens 1995; 13: 397–404.

    Article  CAS  Google Scholar 

  24. Carlquist JF et al. Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74: 918

    Article  CAS  Google Scholar 

  25. Kishimoto C et al. HLA DR2 linkage in patients with apical hypertrophic cardiomyopathy in Japan. Cardiology 1996; 87: 488–491.

    Article  CAS  Google Scholar 

  26. Ross R . Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126.

    Article  CAS  Google Scholar 

  27. Mann DL, Young JB . Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 1994; 105: 897–902.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 4th Department of Internal Medicine, ‘Evangelismos’ State General Hospital, Athens, Greece

    E J Diamantopoulos, E A Andreadis, C V Vassilopoulos, N A Chatzis & G I Tsourous

  2. Department of Medical Statistics, Medical School, University of Crete, Greece

    I G Vlachonikolis

  3. Department of Immunology-Histocompatibility, ‘Evangelismos’ State General Hospital, Athens, Greece

    K E Tarassi & C A Papasteriades

Authors
  1. E J Diamantopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E A Andreadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C V Vassilopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I G Vlachonikolis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K E Tarassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N A Chatzis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G I Tsourous
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C A Papasteriades
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E J Diamantopoulos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diamantopoulos, E., Andreadis, E., Vassilopoulos, C. et al. HLA phenotypes as promoters of cardiovascular remodelling in subjects with arterial hypertension. J Hum Hypertens 17, 63–68 (2003). https://doi.org/10.1038/sj.jhh.1001502

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001502

Keywords

Search

Advanced search

Quick links